Ikarian Capital, LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Ikarian Capital, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $877,908 - $1.26 Million	-14,900 Reduced 14.9%	85,100 $5.27 Million
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $4.61 Million - $6.76 Million	-58,100 Reduced 36.75%	100,000 $7.98 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $7.67 Million - $9.75 Million	-88,800 Reduced 35.97%	158,100 $16.6 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $17.2 Million - $21 Million	-175,000 Reduced 41.48%	246,900 $26.6 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $15.8 Million - $19 Million	171,900 Added 68.76%	421,900 $46.2 Million

Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $33 Million - $36.7 Million	-382,200 Reduced 60.46%	250,000 $23.4 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $24.8 Million - $32.9 Million	-345,000 Reduced 35.3%	632,200 $58.2 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $39.6 Million - $49.8 Million	590,700 Added 152.83%	977,200 $71.5 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $21.3 Million - $30.9 Million	386,500 New	386,500 $30 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.